Why participate in an Alzheimer's disease clinical trial? Is it of benefit to carers and patients?
about
Metal protein attenuating compounds for the treatment of Alzheimer's dementiaAddressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trialsPersonal characteristics and depression-related attitudes of older adults and participation in stages of implementation of a multi-site effectiveness trial (PRISM-E).
P2860
Why participate in an Alzheimer's disease clinical trial? Is it of benefit to carers and patients?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Why participate in an Alzheime ...... enefit to carers and patients?
@en
Why participate in an Alzheime ...... enefit to carers and patients?
@nl
type
label
Why participate in an Alzheime ...... enefit to carers and patients?
@en
Why participate in an Alzheime ...... enefit to carers and patients?
@nl
prefLabel
Why participate in an Alzheime ...... enefit to carers and patients?
@en
Why participate in an Alzheime ...... enefit to carers and patients?
@nl
P2093
P1476
Why participate in an Alzheime ...... enefit to carers and patients?
@en
P2093
Dina LoGiudice
Karen A Sullivan
Maree Mastwyk
Stephen Macfarlane
P304
P577
2003-06-01T00:00:00Z